USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$43.47 USD
+0.33 (0.76%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $43.44 -0.03 (-0.07%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
USNA 43.47 +0.33(0.76%)
Will USNA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for USNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USNA
Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains?
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
USNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
USANA Health Sciences (USNA) Q3 Earnings Miss Estimates
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Earnings Preview: USANA Health Sciences (USNA) Q3 Earnings Expected to Decline
Other News for USNA
Commit To Buy USANA Health Sciences At $22.50, Earn 6% Annualized Using Options
USANA Honored with Local Healthy Worksite Award
RSPS: Consumer Staples Dashboard For April
Small and midcap pair trades for every sector - Oppenheimer
USANA Schedules First Quarter 2024 Earnings Release and Conference Call